# EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs

> **NCT05429476** · PHASE3 · COMPLETED · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 234 (actual)

## Conditions studied

- Stroke, Acute Ischemic

## Interventions

- **DRUG:** Tissue Plasminogen Activator (Alteplase)

## Key facts

- **NCT ID:** NCT05429476
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-17
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-08-15
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429476, "EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05429476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
